PACB | Analyst Upgrades Pacific Biosciences Plunging Stock

PACB stock, Pacific Biosciences of California, Pacific BiosciencesFinding the bottom of a falling penny stock can be valuable for speculators and analysts, but only when the bottom has actually been determined. Pacific Biosciences of California Inc. (PACB), looking to raise capital with the assistance of Cantor Fitzgerald & Co., was upgraded by Wall Street analysts at Maxim Group Friday. Having dropped -76.47% since February, the upgrade ...

Continue Reading →